Calumet, Inc.
Every calculator, already run for CLMT
Open the full toolkit →You have the numbers on CLMT. Get the argument.
A written report on which of these readings actually decide the outcome for Calumet, Inc., what has to stay true for the price to work, and the specific thing that would break it. The first one is free.
Key market data
Analyst consensus
6 analysts covering CLMTAnalyst Price Target Disagreement for Calumet, Inc.
Wall Street's bull case implies +26% from the current price; the bear case implies -46%. A 71% spread signals high analyst disagreement — run your own DCF to anchor on fundamentals rather than street consensus.
Ownership & short interest
About Calumet, Inc.
Calumet, Inc. manufactures, formulates, and markets a slate of specialty branded products and renewable fuels in North America and internationally. It operates through Specialty Products and Solutions; Performance Brands; and Montana/Renewables segments. The Specialty Products and Solutions segment manufactures and markets various solvents, waxes, customized lubricating oils, white oils, petrolatums, gels, esters, and other products. The Montana/Renewables segment processes geographically advantaged renewable feedstocks into renewable diesel, aviation fuel, and renewable naphtha. This segment also engages in the process of Canadian crude oil into conventional gasoline, diesel, jet fuel, and…
CLMT — frequently asked
Is CLMT a buy right now?
Wall Street's consensus rating on Calumet, Inc. is Buy across 6 analysts, with a mean price target of $42.20 (-12% vs. the current $47.72). Ratings are a starting point — run the DCF and check the financial-health readings above before deciding.
Is CLMT overvalued?
CLMT trades at — trailing earnings, against a DCF fair value of $68 per share. The current price implies 2% annual free-cash-flow growth for a decade. Open the DCF or reverse-DCF tool to change the assumptions and see the range.
When is CLMT's next earnings date?
Calumet, Inc. is next scheduled to report earnings around Nov 6, 2026. A full CLMT research report from Basis Report covers the setup into that print — estimates, the beat/miss record, and what would move the thesis.
What is the analyst price target disagreement for Calumet, Inc.?
Analysts covering Calumet, Inc. (CLMT) range from a bear-case target of $26.00 to a bull-case high of $60.00, with a mean consensus target of $42.20 across 5 analysts. The spread of $34.00 (71% of the current price) indicates high disagreement on the outlook. Run the DCF calculator to build your own estimate independent of street consensus.
Compare Calumet, Inc. against related stocks
Explore additional stock overview pages and jump directly into full report generation for each symbol.
Sector peers
Most-followed names in the same sector.
Nearby tickers
Additional public equities from our tracked universe.
Market leaders
Large-cap symbols investors frequently compare.
Investor Guides For Calumet, Inc.
Start with the evergreen guides that matter most for Basic Materials, then move back into the ticker page when you want to pressure-test the framework on a live name.
Generate your full CLMT research report
DCF model, five-year financials, moat assessment, a BUY/HOLD/SELL rating, and the risks that matter — on Calumet, Inc., in minutes. 3 free reports included with every account — no credit card required.